New Hope for Hard-to-Treat Myasthenia Gravis – Medscape

Written by

admin

in

  1. New Hope for Hard-to-Treat Myasthenia Gravis  Medscape
  2. Efgartigimod Promising for Rare Pediatric Disease With Few Treatment Options  Medscape
  3. Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240  Neurology Live
  4. Argenx pulls back curtain on Vyvgart trial win as part of mission to ensure ‘no MG patient is left behind’  Fierce Pharma
  5. MGFA Session 2025: Vyvgart safe, effective in adolescents with gMG  Myasthenia Gravis News

Continue Reading

More posts